List of Novimmune patents

Patents where

Current Assignee

Name

‌

Novimmune

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7728114 Anti-CD3 antibodies and methods of use thereof	Patent 7728114 was granted and assigned to Novimmune on June, 2010 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	7728114	June 1, 2010
‌ US Patent 9850304 Anti-CD3 antibodies and methods of use thereof	Patent 9850304 was granted and assigned to Novimmune on December, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9850304	December 26, 2017
‌ US Patent 9682142 Anti-interferon gamma antibodies and methods of use thereof	Patent 9682142 was granted and assigned to Novimmune on June, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9682142	June 20, 2017
‌ US Patent 9688769 Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers	Patent 9688769 was granted and assigned to Novimmune on June, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9688769	June 27, 2017
‌ US Patent 9926382 Methods for the generation of multispecific and multivalent antibodies	Patent 9926382 was granted and assigned to Novimmune on March, 2018 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9926382	March 27, 2018
‌ US Patent 9234034 Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies	Patent 9234034 was granted and assigned to Novimmune on January, 2016 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9234034	January 12, 2016
‌ US Patent 9828430 Anti-IL-6/IL-6R antibodies	Patent 9828430 was granted and assigned to Novimmune on November, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9828430	November 28, 2017
‌ US Patent 9815909 Readily isolated bispecific antibodies with native immunoglobulin format	Patent 9815909 was granted and assigned to Novimmune on November, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9815909	November 14, 2017
‌ US Patent 8716196 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants	Patent 8716196 was granted and assigned to Novimmune on May, 2014 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	8716196	May 6, 2014
‌ US Patent 9534049 Neutralizing antibodies and methods of use thereof	Patent 9534049 was granted and assigned to Novimmune on January, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9534049	January 3, 2017
‌ US Patent 9650437 Nucleic acid encoding and method of producing anti-IL-17A/IL-17F cross-reactive antibodies	Patent 9650437 was granted and assigned to Novimmune on May, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9650437	May 16, 2017
‌ US Patent 8258267 Human anti-IP-10 antibodies uses thereof	Patent 8258267 was granted and assigned to Novimmune on September, 2012 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	8258267	September 4, 2012
‌ US Patent 9453076 Anti-TLR4 antibodies and uses thereof	Patent 9453076 was granted and assigned to Novimmune on September, 2016 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9453076	September 27, 2016
‌ US Patent 9688755 Fc receptor-binding polypeptides with modified effector functions	Patent 9688755 was granted and assigned to Novimmune on June, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9688755	June 27, 2017
‌ US Patent 7744884 Neutralizing antibodies and methods of use thereof	Patent 7744884 was granted and assigned to Novimmune on June, 2010 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	7744884	June 29, 2010
‌ US Patent 9540444 Neutralizing antibodies and methods of use thereof	Patent 9540444 was granted and assigned to Novimmune on January, 2017 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9540444	January 10, 2017
‌ US Patent 8105595 Methods of using neutralizing anti-TLR4/MD2 antibodies	Patent 8105595 was granted and assigned to Novimmune on January, 2012 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	8105595	January 31, 2012
‌ US Patent 9512221 Anti-TLR4 antibodies and methods of use thereof	Patent 9512221 was granted and assigned to Novimmune on December, 2016 by the United States Patent and Trademark Office.	‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	9512221	December 6, 2016
‌ US Patent 10759858 Anti-CD3 antibodies and methods of use thereof		‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	10759858	September 1, 2020
‌ US Patent 10759862 Anti-IL-6/IL-6R antibodies and methods of use thereof		‌ Novimmune	‌ Novimmune	United States Patent and Trademark Office	10759862	September 1, 2020
‌ US Patent 8921281 Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants	Patent 8921281 was granted and assigned to Novimmune on December, 2014 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	8921281	December 30, 2014
‌ US Patent 7674884 Neutralizing antibodies and methods of use thereof	Patent 7674884 was granted and assigned to Novimmune on March, 2010 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	7674884	March 9, 2010
‌ US Patent 8673299 Anti-RANTES antibodies	Patent 8673299 was granted and assigned to Novimmune on March, 2014 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	8673299	March 18, 2014
‌ US Patent 8034344 Anti-IL-6/IL-6R antibodies and methods of use thereof	Patent 8034344 was granted and assigned to Novimmune on October, 2011 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	8034344	October 11, 2011
‌ US Patent 8029794 Combining therapies targeting multiple toll-like receptors	Patent 8029794 was granted and assigned to Novimmune on October, 2011 by the United States Patent and Trademark Office.		‌ Novimmune	United States Patent and Trademark Office	8029794	October 4, 2011

Results per page:

31 results

0 selected

31 results

0 selected